Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia (Q37039074)

From Wikidata
Jump to navigation Jump to search
scientific article published on 30 April 2013
edit
Language Label Description Also known as
English
Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia
scientific article published on 30 April 2013

    Statements

    Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia (English)
    30 April 2013
    119
    2728-2736

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit